The clinical mass spectrometry market is estimated to be valued at US$ 6.37 Bn in 2023 and is expected to exhibit a CAGR of 6.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Clinical mass spectrometry is a technique employed for analyzing small molecules and biomolecules like proteins, peptides, glycans. It finds wide applications in proteomics, ... Read more
Clinical mass spectrometry finds wide application in clinical research and drug development for disease diagnosis, monitoring disease progression, drug metabolism studies etc. It helps in detection of trace level molecules present in biological samples like blood, urine etc. and provides accurate molecular weight information. The ability of mass spectrometers to perform multitask functions like identification, quantification and structural characterization has increased its demand in ... Read more
Mass spectrometry has revolutionized clinical diagnostics and research by enabling detection and quantification of thousands of molecules in biological samples. This emerging field of clinical mass spectrometry is allowing for more precise disease diagnosis, drug monitoring, and biomarker discovery. This article discusses the application of mass spectrometry in various clinical areas and its promise for advancing personalized medicine.
